EntryPoint Capital’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,968
Closed -$80.4K 1051
2024
Q2
$80.4K Sell
1,968
-2,360
-55% -$96.4K 0.12% 399
2024
Q1
$110K Sell
4,328
-7,086
-62% -$181K 0.1% 362
2023
Q4
$103K Buy
+11,414
New +$103K 0.1% 370